Skip to content

Efficacy of Doll Therapy in the Dementia in Acute Geriatric Inpatients

Efficacy of Doll Therapy in the Control of Behavioral and psychologIcal Symptoms of Dementia in Acute Geriatric Inpatients: the AGITATE Study.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05691569
Acronym
AGITATE
Enrollment
92
Registered
2023-01-20
Start date
2024-11-15
Completion date
2027-08-30
Last updated
2025-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Brief summary

Summary. Behavioral and psychological symptoms of dementia (BPSD) represents a huge emotional stress and an important burden for the patients and the caregivers severely reducing their quality of life. BPSD worsen during hospitalization and require the administration of psychotropic drugs that are often insufficient to control the symptoms, and may cause severe adverse events. The investigators propose the use of empathy dolls in order to reduce BPSD and in particular agitation and aggressiveness in acute geriatric in-patients affected by moderate to severe forms of dementia. The use of doll therapy in the clinical routine will allow to reduce the use of psychotropic drugs, shorten hospitalization, reduce professional and family caregiver burden improving patients' and families' quality of life.

Interventions

empathy dolls

Sponsors

Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This is a randomized controlled open label trial with two parallel arms

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age ≥65 years * diagnosis of dementia moderate to severe Clinical Dementia Rating scale (CDR) ≥2 * presence of agitation and/or aggressiveness * manual and visual abilities sufficient in order to interact with the doll.

Exclusion criteria

* age \<65 years; * refuse to participate; * mild forms of dementia (CDR\<2); * contraindication for DT as experience of mournful or traumatic events related to parental experience; * life expectancy lower than 3 months; * infectious diseases requiring isolation; * negative interaction with the doll, * presence of delirium.

Design outcomes

Primary

MeasureTime frameDescription
agitation and aggressiveness within hospitalbaseline and hospital discharge discharge (up to one week)measured by Pittsburgh Agitation Scale (PAS). the score ranges between 0 to 16 on the PAS the higher score means the higher agitation
behavioural and psychological symptoms of dementiabaseline, discharge (up to one week)Neuro Psychiatic Inventory (NPI). The NPI total score ranges from 0 to 144, higher scores means more severe and frequent behavioural and psycological symptoms of dementia
agitation and aggressiveness outside hospitalbaseline, 1 and 4 weeks after dischargeCohen Mansfield Inventory scale (CMAI). the score ranges betwen 0 and 203, with higher scores indicating more agitation

Secondary

MeasureTime frameDescription
professional caregiver burdenbaseline and at hospital discharge (up to one week)Staff Stress Measure Dementia Care (SSMDC). The scale comprised the following 27 items producing a five-factor solution: Frustrated empathy; difficulties understanding and interpreting; balancing competing needs; balancing emotional involvement; and lack of recognition.
incidence of deliriumevery day during hospital stay (up to one week)measured by the Confusion Assessment Method (CAM) scale. For a diagnosis of delirium by CAM, the patient must display: 1. Presence of acute onset and fluctuating discourse AND 2. Inattention AND EITHER 3. Disorganized thinking OR 4. Altered level of consciousness
family caregiver burdenbaseline and 4 weeks after dischargeCaregiver Burden Inventory (CBI) scale. The Caregiver Burden Inventory comprises 24 closed questions divided into five dimensions: time-dependence, developmental, physical, social and emotional burden. There are five items in each dimension except for physical burden, which has four items dedicated to. Each item is given a score between 0 (not at all descriptive) and 4 (very descriptive), where higher scores indicate greater caregiver burden; there are no cut-off points for classifying burden. Therefore, total scores for factors one, two, four and five can range from zero to 20. An equivalent score for physical burden can be obtained by multiplying the sum of items in this dimension by 1.25
patients' quality of lifebaseline and 4 weeks after dischargeby the use of the AD-5D Dementia Utility Instrument, the scales scores between -1 to 1, the highest score indicate the better quality of life
family caregivers' quality of lifebaseline and 4 weeks after dischargeby the EuroQoL 5-Dimensions 5 level versions. the scale scores from 5 to 25 the highest the score the lowest the quality of life

Countries

Switzerland

Contacts

Primary ContactPatrizia D Amelio, MD, PhD
patrizia.damelio@chuv.ch+41213143712

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026